Functional Genomics Market Report 2026

Functional Genomics Market Overview

• Functional Genomics market size has reached to $14.84 billion in 2025 • Expected to grow to $28.71 billion in 2030 at a compound annual growth rate (CAGR) of 14.1% • Growth Driver: Rising Investment In Research And Development Driving The Growth Of The Market Due To Enhanced Gene Function Analysis And Innovation • Market Trend: Advancements In High-Throughput Sequencing Enabling Rapid And Accurate Genome Analysis • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Functional Genomics Market?

Functional genomics is the study of how genes and other parts of the genome operate and interact within an organism. It seeks to understand the roles of genes in controlling biological processes and how they influence traits and behaviors. By examining patterns of gene activity and the effects of genetic changes, functional genomics reveals the underlying mechanisms that regulate cells, tissues, and entire organisms. The main products of functional genomics include kits and assays and instruments. Kits and assays are standardized laboratory tools designed to detect, quantify, or analyze specific biomolecules, genes, or proteins. It uses various technologies such as next-generation sequencing (NGS), microarray analysis, CRISPR and gene editing technologies, and RNA sequencing (RNA-seq) and is used by several end-users, including academic and research institutes, pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), clinical laboratories, and agricultural biotechnology companies.

What Is The Functional Genomics Market Growth Forecast?

The functional genomics market size is expected to see rapid growth in the next few years. It will grow to $28.71 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising investments in genomic data analytics, expansion of gene editing research applications, growing collaboration between academia and industry, increasing focus on translational genomics research. Major trends in the forecast period include increasing adoption of high-throughput functional genomics tools, rising integration of multi-omics analysis platforms, growing use of ai in gene function interpretation, expansion of automated genomic workflows, enhanced focus on disease mechanism discovery.

Global Functional Genomics Market Segmentation

1) By Product: Kits And Assays, Instruments 2) By Technology: Next-Generation Sequencing (NGS), Microarray Analysis, CRISPR And Gene Editing Technologies, RNA Sequencing (RNA-Seq) 3) By End-User: Academic And Research Institutes, Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs), Clinical Laboratories, Agricultural Biotechnology Companies Subsegments: 1) By Kits And Assays: PCR Kits, Microarray Kits, NGS Kits, Reagents, Enzymes 2) By Instruments: Sequencers, Microarray Scanners, PCR Instruments, Automation Systems

What Is The Driver Of The Functional Genomics Market?

The increasing investment in research and development is expected to propel the growth of the functional genomics market going forward. Research and development is the organized effort to create, improve, and innovate products, processes, or knowledge through investigation and experimentation. Investment in research and development is rising as companies are increasingly seeking innovation to stay competitive, driving them to allocate more resources toward developing new products, improving technologies, and capturing emerging market opportunities. Investment in research and development benefits functional genomics by advancing the identification and analysis of gene functions, thereby enhancing our understanding of complex biological processes and supporting the creation of precise therapeutic strategies. For instance, in February 2024, according to Biospace, a US-based online pharmaceuticals platform, it posted that in 2023, global biopharma research and development (R&D) funding rose to $72 billion, up from $61 billion in 2022. Therefore, the increasing investment in research and development is driving the growth of the functional genomics industry.

Key Players In The Global Functional Genomics Market

Major companies operating in the functional genomics market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., Phase Genomics Inc.

Global Functional Genomics Market Trends and Insights

Major companies operating in the functional genomics market are focusing on developing advanced approaches, such as high-throughput sequencing, to provide highly accurate and detailed insights into complex genomes. High-throughput sequencing is a method that allows rapid and simultaneous sequencing of large amounts of DNA or RNA to analyze genetic information on a broad scale. For instance, in February 2025, Roche, a Switzerland-based pharmaceutical company, launched sequencing by expansion (SBX) technology, creating a new category of next-generation sequencing. SBX chemistry, along with an advanced sensor module, enables ultra-fast, high-throughput sequencing that is adaptable and scalable for a wide range of applications. This innovative technique translates the sequence of DNA or RNA into a detectable surrogate polymer called an Xpandomer through a precise biochemical process. Xpandomers, which are fifty times longer than the original nucleic acid, convert sequence information into strong, low-noise signals for clear and reliable detection. By utilizing a CMOS-based sensor with parallel processing, this method achieves highly accurate single-molecule nanopore sequencing with exceptional speed and versatility.

What Are Latest Mergers And Acquisitions In The Functional Genomics Market?

In January 2025, Vividion Therapeutics Inc., a US-based biopharmaceutical company specializing in discovering and developing small-molecule therapeutics, acquired Tavros Therapeutics Inc. for an undisclosed amount. Through this acquisition, Vividion aims to expand its functional genomics capabilities and enhance drug discovery, particularly in oncology and immunology, by integrating Tavros’s genomic screening platform with Vividion’s chemoproteomics expertise, enabling the identification of novel drug targets. Tavros Therapeutics, Inc. is a US-based biotechnology company specializing in genomic screening technologies for target discovery.

Regional Outlook

North America was the largest region in the functional genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Functional Genomics Market?

The functional genomics market consists of revenues earned by entities by providing services such as gene expression profiling, epigenomic profiling, phenotypic screening, and variant effect analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The functional genomics market also includes sales of microarray scanners, thermal cyclers, fluorometers, and bioanalyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Functional Genomics Market Report 2026?

The functional genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the functional genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.